Our vision is to reduce the personal and societal burden of food allergy, through improving management and developing cures.

Food allergy is one of the most common chronic conditions affecting children in Westernised countries, with rates having increased exponentially in recent decades. Allergist Immunologist and Clinician Researcher Professor Mimi Tang leads our group, bringing significant clinical and laboratory-based expertise to the role.

The group members bring broad experience in:

  • Clinical, basic immunology and patient-important outcomes research
  • Commercialisation expertise to conduct high-quality multi-centre randomised controlled clinical trials evaluating novel interventions for the treatment of food allergies
  • Investigating immunological mechanisms underlying allergy versus tolerance to inform the development of innovative next-generation treatments
  • Developing support tools that can be rapidly implemented to keep children with food allergy safe

The Allergy Immunology group also collaborates on randomised trials evaluating prevention strategies (VITALITY, PEBBLES) and longitudinal cohort studies investigating risk factors for food allergy and other allergic disorders (Barwon Infant Study, HealthNuts, SchoolNuts, EarlyNuts) to facilitate the identification of novel prevention strategies.

Related news

Improving the lives of children and families living with food allergy

Watch as Stella speaks to Allergist Immunologist, Professor Mimi Tang about her role at MCRI.